Related Experiment Video
Updated: Jun 6, 2025
09:51
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
756
Selective autophagy receptor hinders antitumor immunity.
Jiao Liu1, Rui Kang2, Daolin Tang2
1DAMP Laboratory, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510150, China.
Trends in Cancer
|December 3, 2024
Summary
Immunity-related GTPase Q (IRGQ) acts as an autophagy receptor in liver cancer, degrading immune-suppressing molecules. This finding reveals a new target for improving cancer immunotherapy effectiveness.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- Autophagy plays a complex role in cancer development and treatment.
- Specific autophagy receptors and cargo selection are crucial for its function.
- Immune evasion is a key mechanism tumors use to survive therapy.
Purpose of the Study:
- To identify novel autophagy receptors involved in cancer.
- To investigate the role of IRGQ in hepatocellular carcinoma (HCC).
- To explore IRGQ's mechanism in immune evasion and its therapeutic implications.
Main Methods:
- Utilized molecular biology techniques to identify and characterize autophagy receptors.
- Investigated the interaction between IRGQ, autophagy machinery, and target molecules.
- Analyzed the impact of IRGQ on immune evasion in HCC models.
Main Results:
- Identified immunity-related GTPase Q (IRGQ) as a novel autophagy receptor.
- Demonstrated that IRGQ facilitates the degradation of histocompatibility complex class I (MHC-I) molecules.
- Showed that IRGQ promotes immune evasion in hepatocellular carcinoma (HCC).
Conclusions:
- IRGQ is a key player in autophagy-mediated immune evasion in HCC.
- Targeting IRGQ could be a strategy to enhance immunotherapy for liver cancer.
- Further research into IRGQ's role may uncover new therapeutic avenues.
Related Concept Videos
01:27Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:18Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
01:36Delivery Pathways to the Lysosome
6.1K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.1K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K